menu
    • menu

    Company profile for Seres Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics. Seres Therapeutics is creating a new class of medicines using live bacteria to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Seres TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 Sidney Street Cambridge, MA 02139
    Telephone
    Telephone
    617-945-9626
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.serestherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/seres-health/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/serestx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Seres Therapeutics Joins Piper Sandler Healthcare Conference
    Seres Therapeutics Joins Piper Sandler Healthcare Conference

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193361/0/en/Seres-Therapeutics-to-Participate-in-Piper-Sandler-Healthcare-Conference.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Seres Therapeutics Unveils Q3 2025 Financials & Business
    Seres Therapeutics Unveils Q3 2025 Financials & Business

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181292/0/en/Seres-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Updates.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Seres Therapeutics to Unveil Q3 2025 Financials Results
    Seres Therapeutics to Unveil Q3 2025 Financials Results

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177214/0/en/Seres-Therapeutics-to-Announce-Third-Quarter-2025-Financial-Results-and-Business-Updates-on-November-5-2025.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Seres Gets Up To $3.6M From CARB-X For SER-155 Formulation
    Seres Gets Up To $3.6M From CARB-X For SER-155 Formulation

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176257/0/en/Seres-Therapeutics-Receives-Award-of-Up-to-3-6-Million-from-CARB-X-to-Develop-Liquid-Formulation-of-SER-155.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    Seres Therapeutics Showcases SER-155 Phase 1B Trial Data
    Seres Therapeutics Showcases SER-155 Phase 1B Trial Data

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166025/0/en/Seres-Therapeutics-to-Present-New-Post-Hoc-Data-From-SER-155-Phase-1b-Trial-at-IDWeek-2025-Highlighting-Potential-to-Improve-Outcomes-in-Adults-Undergoing-Allogeneic-Hematopoietic-.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    Seres Reduces Head Count by 25% to Fund Biotherapeutic's Ph 2
    Seres Reduces Head Count by 25% to Fund Biotherapeutic's Ph 2

    23 Sep 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/seres-shrinks-headcount-25-fund-phase-2-study-biotherapeutic

    FIERCE BIOTECH
    23 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search